123 related articles for article (PubMed ID: 37589154)
1. Systolic Blood Pressure Time in Target Range and Incident Atrial Fibrillation in Patients With Hypertension: Insights From the SPRINT Trial.
Wang J; Jiang C; Li S; Wang Z; Wang Y; Lai Y; Wang Z; Lv W; Bai Y; Yang Z; Guo Q; Huang L; He L; Guo X; Li S; Liu N; Jiang C; Tang R; Long D; Du X; Sang C; Dong J; Ma C
Hypertension; 2023 Nov; 80(11):2306-2314. PubMed ID: 37589154
[TBL] [Abstract][Full Text] [Related]
2. Systolic Blood Pressure Time in Target Range and Cognitive Outcomes: Insights From the SPRINT MIND Trial.
Li S; Jiang C; Wang Y; Lai Y; Zhao M; Li Q; Bai Y; Dai W; Guo Q; He L; Guo X; Wang W; Li S; Liu N; Jiang C; Tang R; Sang C; Long D; Du X; Dong J; Anderson CS; Ma C
Hypertension; 2023 Aug; 80(8):1628-1636. PubMed ID: 37165869
[TBL] [Abstract][Full Text] [Related]
3. Effect of Intensive Blood Pressure Lowering on the Risk of Atrial Fibrillation.
Soliman EZ; Rahman AF; Zhang ZM; Rodriguez CJ; Chang TI; Bates JT; Ghazi L; Blackshear JL; Chonchol M; Fine LJ; Ambrosius WT; Lewis CE
Hypertension; 2020 Jun; 75(6):1491-1496. PubMed ID: 32362229
[TBL] [Abstract][Full Text] [Related]
4. Effect of lower on-treatment systolic blood pressure on the risk of atrial fibrillation in hypertensive patients.
Okin PM; Hille DA; Larstorp AC; Wachtell K; Kjeldsen SE; Dahlöf B; Devereux RB
Hypertension; 2015 Aug; 66(2):368-73. PubMed ID: 26056336
[TBL] [Abstract][Full Text] [Related]
5. Incidence and Implications of Atrial Fibrillation/Flutter in Hypertension: Insights From the SPRINT Trial.
Parcha V; Patel N; Kalra R; Kim J; Gutiérrez OM; Arora G; Arora P
Hypertension; 2020 Jun; 75(6):1483-1490. PubMed ID: 32362231
[TBL] [Abstract][Full Text] [Related]
6. Time in target range of systolic blood pressure and cognitive outcomes in patients with hypertension.
Huang X; Deng S; Xie W; Zheng F
J Am Geriatr Soc; 2024 Feb; 72(2):423-432. PubMed ID: 37916517
[TBL] [Abstract][Full Text] [Related]
7. Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation: The AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management).
Proietti M; Romiti GF; Olshansky B; Lip GYH
Hypertension; 2017 Nov; 70(5):949-958. PubMed ID: 28974568
[TBL] [Abstract][Full Text] [Related]
8. Effects of intensive blood pressure control on cardiovascular and cognitive outcomes in patients with atrial fibrillation: insights from the SPRINT trial.
Jiang C; Lai Y; Du X; Wang Y; Li S; He L; Hu R; Lv Q; Wu J; Feng L; Ning M; Ruan Y; Li X; Jia C; Dai W; Guo X; Jiang C; Tang R; Sang C; Long D; Arima H; Dong J; Anderson CS; Ma C
Europace; 2022 Oct; 24(10):1560-1568. PubMed ID: 35640916
[TBL] [Abstract][Full Text] [Related]
9. Systolic and diastolic blood pressure time in target range and cardiovascular outcomes in patients with hypertension and pre-frailty or frailty status.
Zhu J; Yang K; Liu W
J Clin Hypertens (Greenwich); 2024 May; 26(5):514-524. PubMed ID: 38552135
[TBL] [Abstract][Full Text] [Related]
10. Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Risk of Heart Failure and Atrial Fibrillation.
Kaneko H; Yano Y; Itoh H; Morita K; Kiriyama H; Kamon T; Fujiu K; Michihata N; Jo T; Takeda N; Morita H; Node K; Carey RM; Lima JAC; Oparil S; Yasunaga H; Komuro I
Circulation; 2021 Jun; 143(23):2244-2253. PubMed ID: 33886370
[TBL] [Abstract][Full Text] [Related]
11. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure control and risk of incident atrial fibrillation.
Thomas MC; Dublin S; Kaplan RC; Glazer NL; Lumley T; Longstreth WT; Smith NL; Psaty BM; Siscovick DS; Heckbert SR
Am J Hypertens; 2008 Oct; 21(10):1111-6. PubMed ID: 18756257
[TBL] [Abstract][Full Text] [Related]
13. Association of long-term time in target range for systolic blood pressure with cardiovascular risk in the elderly: a Chinese veteran cohort study.
Lin Z; Xiao Z; Chen W; Xu W; Huang C; Xie J; Jin M; Wei X; He S; Xie Z; Liao W; Liao Y; Feng W; Chen Y; Bin J
Eur J Prev Cardiol; 2023 Aug; 30(10):969-977. PubMed ID: 36947144
[TBL] [Abstract][Full Text] [Related]
14. Systolic Blood Pressure and Effects of Screening for Atrial Fibrillation With Long-Term Continuous Monitoring (a LOOP Substudy).
Xing LY; Diederichsen SZ; Højberg S; Krieger DW; Graff C; Olesen MS; Brandes A; Køber L; Haugan KJ; Svendsen JH
Hypertension; 2022 Sep; 79(9):2081-2090. PubMed ID: 35862138
[TBL] [Abstract][Full Text] [Related]
15. Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
Beddhu S; Chertow GM; Cheung AK; Cushman WC; Rahman M; Greene T; Wei G; Campbell RC; Conroy M; Freedman BI; Haley W; Horwitz E; Kitzman D; Lash J; Papademetriou V; Pisoni R; Riessen E; Rosendorff C; Watnick SG; Whittle J; Whelton PK;
Circulation; 2018 Jan; 137(2):134-143. PubMed ID: 29021322
[TBL] [Abstract][Full Text] [Related]
16. Systolic Blood Pressure Time in Target Range and Major Adverse Kidney and Cardiovascular Events.
Buckley LF; Baker WL; Van Tassell BW; Cohen JB; Alkhezi O; Bress AP; Dixon DL
Hypertension; 2023 Feb; 80(2):305-313. PubMed ID: 36254738
[TBL] [Abstract][Full Text] [Related]
17. Interaction of Blood Pressure and Body Mass Index With Risk of Incident Atrial Fibrillation in a Japanese Urban Cohort: The Suita Study.
Kokubo Y; Watanabe M; Higashiyama A; Nakao YM; Kobayashi T; Watanabe T; Okamura T; Okayama A; Miyamoto Y
Am J Hypertens; 2015 Nov; 28(11):1355-61. PubMed ID: 25845964
[TBL] [Abstract][Full Text] [Related]
18. Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical Trial.
Ghazi L; Shen J; Ying J; Derington CG; Cohen JB; Marcum ZA; Herrick JS; King JB; Cheung AK; Williamson JD; Pajewski NM; Bryan N; Supiano M; Sonnen J; Weintraub WS; Greene TH; Bress AP
JAMA Netw Open; 2023 May; 6(5):e2314443. PubMed ID: 37204788
[TBL] [Abstract][Full Text] [Related]
19. Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 Trial.
Park S; Bergmark BA; Shi M; Lanz HJ; Chung N; Ruff CT; Antman EM; Braunwald E; Giugliano RP
Hypertension; 2019 Sep; 74(3):597-605. PubMed ID: 31352829
[TBL] [Abstract][Full Text] [Related]
20. Relationship of Hypertension and Systolic Blood Pressure With the Risk of Stroke or Bleeding in Patients With Atrial Fibrillation: The Fushimi AF Registry.
Ishii M; Ogawa H; Unoki T; An Y; Iguchi M; Masunaga N; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M
Am J Hypertens; 2017 Nov; 30(11):1073-1082. PubMed ID: 28575205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
